Experimental setup. by Shinnosuke Hase (20917896)

“…Conversely, the fast-rhythm auditory guide significantly increased step rate and decreased step length (p <  0.05). …”

List of Included studies. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

The search strategy in three databases. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

NIH score. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

List of excluded studies. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

Step length asymmetry and step width during split-belt adaptation. by Samantha Jeffcoat (22783930)

Comparison of serum VEGF-A165 concentrations pre-bevacizumab administration in patients with increased VEGF-A post-bevacizumab administration and those with decreased VEGF-A. by Masashi Okawa (8951294)

Subjects:

Microscopic view of <i>spirulina</i> spp. by Maha Rehman (17114332)

Subjects:

Supplementary data file of graphs. by Maha Rehman (17114332)

Subjects:

Fig 3 - by Maha Rehman (17114332)

Subjects:

Fig 5 - by Maha Rehman (17114332)

Subjects:

Fig 4 - by Maha Rehman (17114332)

Subjects:

The primer sequences of real-time PCR. by Lihan Xu (18778257)

Subjects:

The impact of UV360 on the development of spinal motor neuron axons in zebrafish larvae. by Lihan Xu (18778257)

Subjects:

The impact of UV360 on the locomotor activity of zebrafish larvae. by Lihan Xu (18778257)

Subjects:

The outcomes of transcriptome analyses. by Lihan Xu (18778257)

Subjects:

The impact of UV360 on the viability and developmental progression of zebrafish embryos. by Lihan Xu (18778257)

Subjects:

The impact of UV360 on the neurophysiological activity of zebrafish larvae. by Lihan Xu (18778257)

Subjects:

Flow chart. by Raphaele Houlbracq (20558509)

Subjects:

HSP90 inhibition by RGRN-305 decreased the gene expression of proinflammatory cytokines induced by SARS-CoV-2 S protein. by Hakim Ben Abdallah (14578241)